Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation
✍ Scribed by Florian Langer; Brigitte Spath; Katja Haubold; Katharina Holstein; Guy Marx; Jan Wierecky; Tim H. Brümmendorf; Judith Dierlamm; Carsten Bokemeyer; Barbara Eifrig
- Book ID
- 105989092
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 248 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ± 90 pg/ml) and TFPI (252 ± 125 ng/ml) levels wer
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer
Plasma levels of tissue factor pathway inhibitor (TFPI)-activated factor Xa (FXa) complex were measured in patients with disseminated intravascular coagulation (DIC), pre-DIC, and DIC. Plasma levels of plasmin-plasmin inhibitor complex (PPIC), D-dimer, and soluble fibrin monomer (SFM) were significa
To evaluate that the relationship between the truncated form of tissue factor pathway inhibitor (TFPI) and the stage of disseminated intravascular coagulation (DIC), we measured the plasma levels of tissue factor (TF) antigen and the intact and truncated forms of TFPI antigens in 41 patients with DI